|
Report No. : |
334725 |
|
Report Date : |
01.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
SANDOZ
GMBH |
|
|
|
|
Registered Office : |
Biochemiestraße
10, A-6250 Kundl |
|
|
|
|
Country : |
Austria |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Year of Establishment : |
1965 |
|
|
|
|
Com. Reg. No.: |
3630 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Subject is manufacture of pharmaceutical preparations |
|
|
|
|
No. of Employee : |
3630 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Austria |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
AUSTRIA - ECONOMIC OVERVIEW
Austria, with its well-developed market economy, skilled labor force, and high standard of living, is closely tied to other EU economies, especially Germany's. Its economy features a large service sector, a relatively sound industrial sector, and a small, but highly developed agricultural sector. Economic growth was anemic at less than 0.5% in 2013 and 2014, and growth in 2015 is not expected to exceed 0.5%. Austria’s 5.6% unemployment rate, while low by European standards, is at an historic high for Austria. Without extensive vocational training programs and generous early retirement, the unemployment rate would be even higher. Public finances have not stabilized even after a 2012 austerity package of expenditure cuts and new revenues. On the contrary, in 2014, the government created a “bad bank” for the troubled nationalized “Hypo Alpe Adria” bank, pushing the budget deficit up by 0.9% of GDP to 2.4% and public debt to 84.5% of the GDP. Although Austria's fiscal position compares favorably with other euro-zone countries, it faces several external risks, such as Austrian banks' continued exposure to Central and Eastern Europe, repercussions from the Hypo Alpe Adria bank collapse, political and economic uncertainties caused by the European sovereign debt crisis, the current crisis in Russia/Ukraine, the recent appreciation of the Swiss Franc, and political developments in Hungary.
|
Source
: CIA |
SANDOZ GMBH
Biochemiestraße
10, A-6250 Kundl
|
Phone: |
(0043)
5338 200 |
|
Fax: |
(0043)
5338 200 - 415 |
|
E-mail: |
kundl.austria@sandoz.com |
|
Internet: |
http://www.sandoz.com |
|
Internet: |
http://www.sandoz.at |
ÖNACE
21200 100% Manufacture of pharmaceutical preparations
|
Submitted
for collection on |
Submitted
amount |
Amount
paid so far |
Outstanding
amount |
Last
status of debt collection |
Status
as of |
|||
|
2014-12-19 |
EUR |
508,21 |
EUR |
508,21 |
EUR |
0,00 |
Payment
of balance (outstanding) |
2015-01-20 |
|
2013-05-16 |
EUR |
578,31 |
EUR |
578,31 |
EUR |
0,00 |
Payment
after KSV1870 debt collection |
2013-06-17 |
|
2012-11-08 |
EUR |
348,96 |
EUR |
348,96 |
EUR |
0,00 |
Payment
after KSV1870 debt collection |
2012-12-04 |
|
Summen |
EUR |
1.435,48 |
EUR |
1.435,48 |
EUR |
0,00 |
|
|
Financial
details can also be entered during the period, irrespective of the balance
sheet date.
|
total
turnover (total sales) |
2014 |
EUR |
1.520.000.000,00 |
(estimated) |
|
total
turnover (total sales) |
2013 |
EUR |
1.496.118.876,88 |
(exact) |
|
total
turnover (total sales) |
2012 |
EUR |
1.449.492.227,45 |
(exact) |
|
total
turnover (total sales) |
2011 |
EUR |
1.480.566.195,12 |
(exact) |
|
total
turnover (total sales) |
2010 |
EUR |
1.428.954.760,56 |
(exact) |
|
total
investments |
2013 |
EUR |
159.715.369,74 |
(exact) |
|
total
employees |
2015 |
|
3630 |
(approx.) |
|
Company
name |
SANDOZ
GMBH |
|||
|
Year
of incorporation |
1965 |
|||
|
Type
of company |
Manufacturing |
|||
|
Legal
form |
limited
liability company since 1965-11-18 |
|||
|
Companies
house number |
FN
50587 v Innsbruck since 1965-11-26 |
|||
|
Export |
|
|||
|
ARA-number |
3462 |
|||
|
VAT
number |
ATU
32425809 |
|||
|
number
- Austrian National Bank |
4812 |
|||
|
Last
balance sheet: |
2013 |
|||
|
Banking
connection |
|
|
operational |
A-6250
Kundl, Biochemiestraße 10 |
registered
office |
|
operational |
A-6250
Kundl, Biochemiestraße 10 |
registered
headquarters, owned property |
|
|
0043
5338 200 |
kundl.austria@sandoz.com |
|
operational |
A-1230
Wien, Brunnerstraße 59 |
branch
office, rented premises |
|
|
0043
1 866590 |
|
|
operational |
A-6330
Kufstein, Schaftenau Biochemiestraße 10 |
factory,
owned property |
|
|
0043
5372 6996 |
|
|
operational |
A-6250
Kundl, Dr. Hans Bachmannstraße 7, (umben.auf Biochemiestraße 10) |
registered
headquarters |
|
former |
A-1220
Wien, Wagramerstraße 19 |
branch
office |
|
Surname |
Date
of birth |
Address |
Executive
positions |
Further
executive positions (as registered in the companies' house) |
|
Mag.
Hubert Hirzinger |
1957-05-10 |
A-6250
Kundl Biochemiestraße
10 (p/A Sandoz GmbH) |
manager |
4 |
|
Dkfm.
Klaus Neumayer |
1964-07-17 |
A-6250
Kundl Biochemiestraße
10 |
manager |
0 |
|
Dr.
Thomas Nothegger |
1967-07-11 |
A-6250
Kundl c/o
Sandoz GmbH Biochemiestraß 10 |
manager |
0 |
|
Dr.
Konrad Schaefer |
1960-10-08 |
A-6250
Kundl Schieferrollstraße
13 |
manager |
0 |
|
Dr.
Jens Scheibner |
1968-11-15 |
A-6250
Kundl c/o
Sandoz GmbH Biochemiestraß 10 |
manager |
0 |
|
Mag.
Hans Peter Amon |
1975-01-19 |
A-1020
Wien Stella
Klein Löwweg 17 |
joint
signing clerk head of accounting |
4 |
|
Dkfm.
Michael Friedhofen |
1967-08-27 |
A-1020
Wien Stella
Klein Löwweg 17 |
joint
signing clerk |
1 |
|
Sibylla
Härtel |
1962-10-21 |
A-6250
Kundl Biochemiestraße
10(c/o) |
joint
signing clerk |
0 |
|
Dip.-Chem.
Michael Kocher |
1967-04-12 |
A-6250
Kundl c/o
Sandoz GmbH Biochemiestraß 10 |
joint
signing clerk |
0 |
|
Dr.
Nikolaus Kofler |
1968-12-05 |
A-6250
Kundl c/o
Sandoz GmbH Biochemiestraß 10 |
joint
signing clerk |
0 |
|
Dr.
Christopher Manuel Mader |
1973-04-10 |
A-6250
Kundl c/o
Sandoz GmbH Biochemiestraß 10 |
joint
signing clerk |
0 |
|
Rodrigo
Goarmon Pedroso Santos-Ferreira |
1978-11-10 |
A-1020
Wien Stella
Klein Löwweg 17 |
joint
signing clerk |
2 |
|
|
Ferreira |
|||
|
Mag.
Ingrid Schwarzenberger |
1958-03-20 |
A-6250
Kundl Biochemiestraße
10(c/o) |
joint
signing clerk |
0 |
|
Dr.
Josef Egerbacher |
1958-11-20 |
A-6250
Kundl Biochemiestraße
10(c/o) |
chairman
of the supervisory board member of the supervisory board |
0 |
|
Dr.
Andreas Brutsche |
1962-09-17 |
D-83607
Holzkirchen Industriestraße
25 |
deputy
chairman of the supervisory board |
0 |
|
Barbara
Nerad |
1962-12-30 |
A-6250
Kundl Biochemiestraße
10 |
member
of the supervisory board |
0 |
|
Helmut
Pancheri |
1961-07-05 |
A-6250
Kundl Biochemiestraße
10(c/o) |
member
of the supervisory board |
0 |
|
Sandrine
Charlotte Philippe Piret-Gerard |
1975-10-17 |
D-83607
Holzkirchen c/o
HEXAL AG Industriestraße 25 |
member
of the supervisory board |
0 |
|
Felix
Senn |
1959-05-26 |
CH-4056
Basel Novartis
Campus Forum 1 |
member
of the supervisory board |
0 |
|
Mag.
Max Leitinger |
|
A-6250
Kundl Biochemiestraße
10(c/o) |
head
of EDP |
0 |
|
Josef
Postl |
|
A-6250
Kundl Biochemiestraße
10(c/o) |
technical
director |
0 |
|
Company
name |
Address |
Shareholdings
in % |
Since |
Commercial
register no. |
|
Shares
in this company are held by: |
||||
|
Novartis
Austria GmbH |
A-1020
Wien Stella
Klein Löwweg 17 |
99,99
% |
2006-07-27 |
FN
274620 d |
|
Novartis
Holding AG |
CH-4056
Basel Lichtstraße
35 |
0,01
% |
1997-02-22 |
|
|
|
||||
|
This
company holds 100% of the shares in: |
||||
|
HEXAL
PHARMA GmbH |
A-1020
Wien Stella
Klein Löwweg 17 |
100
% |
2005-12-17 |
FN
44896 z |
|
Novartis
Institutes for Biomedical Research GmbH |
A-6250
Kundl Biochemiestraße
10 |
100
% |
1993-08-13 |
FN
43251 f |
|
|
||||
|
|
||||
|
This
company holds less than 50% of the shares in: |
||||
|
Nabriva
Therapeutics AG |
A-1112
Wien Leberstraße
20 |
3,35
% |
|
FN
269261 y |
|
|
||||
|
Affiliated
companies and further participations: |
||||
|
Novartis
Institutes for BioMedical Research GmbH & Co KG |
A-1235
Wien Brunnerstraße
59 |
|
2004-10-23 |
FN
253505 b |
|
Austrian
Center of Biopharmaceutical Technology |
A-1190
Wien Muthgasse
18 |
|
|
|
|
HBHG
Pharma Ges.m.b.H. |
A-4866
Unterach Attersee Mondseestraße
11 |
|
|
FN
215663 b |
|
Novartis
Pharma GmbH |
A-1020
Wien Stella
Klein Löwweg 17 |
|
|
FN
41622 i |
|
EBEWE
Spezial-Pharma Holding GmbH |
A-1020
Wien Stella
Klein Löwweg 17 |
|
|
FN
331193 z |
|
|
||||
(absolute) all amounts in EUR
|
|
2013-12-31 |
|
Franchises,
patents, licences, trademarks and similar rights and advantages |
10.517.586,87 |
|
Sum
intangible assets |
10.517.586,87 |
|
Land
and leasehold rights with buildings thereon including building on land owned
by third parties |
272.157.348,76 |
|
Other
operating and business equipment |
19.349.235,85 |
|
Technical
plants and machines |
147.003.610,97 |
|
Advanced
payments and constructions in progress |
85.077.459,40 |
|
Sum
tangible assets |
523.587.654,98 |
|
Shares
on related firms |
56.831.602,18 |
|
Other
shareholdings |
1.751.901,77 |
|
Other
financial assets, values and securities of fixed assets |
18.051.774,04 |
|
Sum
financial assets |
76.635.277,99 |
|
Sum
fixed assets |
610.740.519,84 |
|
Raw-,
auxiliary materials and supplies |
80.531.973,71 |
|
Unfinished
products |
154.198.842,07 |
|
Finished
products |
37.655.853,59 |
|
Sum
stock |
272.386.669,37 |
|
Claims
from delivered goods and performed services |
130.329.080,94 |
|
Claims
against related firmes Claims against companies with shareholding
relationship |
141.547.017,72 |
|
Other
claims and assets |
54.046.409,90 |
|
Sum
claims |
325.922.508,56 |
|
Cash
on hand, cheques and bank deposits |
4.781.773,95 |
|
Sum
cash and bank |
4.781.773,95 |
|
Sum
current assets |
603.090.951,88 |
|
Deferred
charges |
949.397,27 |
|
Sum
deferred charges |
949.397,27 |
|
Assets |
1.214.780.868,99 |
|
|
|
|
Subscribed/declared
capital |
32.703.000,00 |
|
Legal
reserves |
3.270.300,00 |
|
Free
reserves |
99.991.891,44 |
|
Balance
sheet profit/balance sheet loss |
0,00 |
|
Sum
equity capital |
135.965.191,44 |
|
Other
reserves before taxes |
24.061.760,15 |
|
Sum
reserves before taxes |
24.061.760,15 |
|
Investment
contributions |
557.404,46 |
|
Sum
floor capital |
557.404,46 |
|
Reserves
for severance pays |
47.244.982,00 |
|
Reserves
for pensions |
62.223.887,00 |
|
Other
reserves |
75.068.795,26 |
|
Sum
reserves |
184.537.664,26 |
|
Liabilities
against credit institutes |
4.416.356,48 |
|
Received
advanced payments for orders |
6.711.020,99 |
|
Liabilities
from delivered goods and performed services |
121.144.856,15 |
|
Liabilities
against related firms |
718.491.287,70 |
|
Liabilities
against firm with shareholding relationship |
2.476.066,96 |
|
Other
liabilities |
7.970.213,28 |
|
Other
loans |
1.474.413,00 |
|
Sum
liabilities |
862.684.214,56 |
|
|
|
|
Deferred
income |
6.974.634,12 |
|
Sum
deferred income |
6.974.634,12 |
|
Liabilities |
1.214.780.868,99 |
|
Contingent
liabilities |
1.700.000,00 |
|
Balance
sheet sum |
1.214.780.868,99 |
|
|
|
(absolute) all
amounts in EUR
|
|
2013-12-31 |
|
Gross
sales |
1.496.118.876,88 |
|
Increase
or decrease in finished and unfinished goods and in service claims |
-3.688.594,78 |
|
Other
manufacturing costs capitalized |
4.943.709,32 |
|
Total
turnover or gross profit |
1.497.373.991,42 |
|
|
|
|
Profits
from retirement of fixed assets, except financial assets |
52.284,01 |
|
Other
operating profits |
25.610.882,10 |
|
Other
operating profits totally |
25.663.166,11 |
|
|
|
|
Costs
for obtained services |
-35.905.614,21 |
|
Material
costs |
-812.029.603,51 |
|
Costs
for obtained services totally |
-847.935.217,72 |
|
|
|
|
Wages |
-27.252.938,16 |
|
Salaries |
-159.084.034,37 |
|
Costs
for severance pays |
-3.639.921,46 |
|
Costs
for old age pension |
-6.652.421,94 |
|
Legal
fringe benefits and other payments depending on salaries |
-48.815.704,62 |
|
Other
social fringe benefits |
-6.969.046,50 |
|
Personnel
expenses totally |
-252.414.067,05 |
|
|
|
|
Depreciation
of intangible assets, tangible assets,activated expenses for the set up and
expansion of business operation |
-67.475.792,73 |
|
Depreciation
tangible assets / intangible assets totally |
-67.475.792,73 |
|
|
|
|
Other
operating costs |
-314.828.351,82 |
|
Other
taxes |
-582.752,31 |
|
Total
costs |
-315.411.104,13 |
|
|
|
|
Operating
result totally |
39.800.975,90 |
|
|
|
|
Profits
from shareholdings |
11.027.987,22 |
|
Income
from other securities and loans of financial assets |
551.302,92 |
|
Interest
income, securties income and similar income |
99,97 |
|
Interest
and similar disbursements |
-11.860.973,78 |
|
Financial
profits totally |
-281.583,67 |
|
|
|
|
Results
from usual business activity totally |
39.519.392,23 |
|
|
|
|
Taxes
on income and profits |
-8.044,52 |
|
Taxes
on income and profits totally |
-8.044,52 |
|
|
|
|
Annual
surplus/annual deficit totally |
39.511.347,71 |
|
|
|
|
Dissolution
reserves before taxes |
824.117,96 |
|
Transfer
to profit reserves |
-40.335.465,67 |
|
Reserves
movements totally |
-39.511.347,71 |
|
|
|
|
B/S
profit/ B/S loss from profit and loss account |
0,00 |
|
|
|
|
|
2013 |
|
Cashflow
II |
106.987.140,44 |
|
Debt
amortisation period in years |
9,68 |
|
Bank
indebtedness |
0,48 |
|
Equity
capital share in % |
13,29 |
|
Social
capital share |
9,01 |
|
Fixed
assets coverage |
44,21 |
|
Net
profit ratio |
2,63 |
|
Capital
turnover |
1,23 |
|
Return
on investment in % |
4,22 |
|
Cashflow
in % of operating performance |
7,14 |
|
Cashflow
I |
106.995.184,96 |
|
Gross
productivity |
5,93 |
|
Net
productivity |
2,57 |
|
Operating
performance |
1.497.373.991,42 |
|
Inventories
in % of operating performance |
18,19 |
|
Gross
profit |
649.438.773,70 |
|
Last
check |
2015-07-29 |
|
Entry
number |
Cadastral
community |
Journal
number |
|
100 |
Kundl T 83108 |
2567/2013 |
|
Section
A – type of property: |
|
GST-NR G BA (NUTZUNG) FLÄCHE GST-ADRESSE |
|
Section
B – ownership structure: |
|
1
ANTEIL: 1/1 |
|
Section
C – encumbrances: |
|
3 a 1589/1993 |
|
firm
(style) |
63 Sandoz GmbH |
|
legal
form |
1 Gesellschaft mit beschränkter Haftung |
|
registered
office |
1 politischer Gemeinde Kundl |
|
business
adress |
15 Biochemiestraße 10 |
|
capital |
52 EUR 32.703.000 |
|
reference
date annual accounts |
1 31. Dezember |
|
annual
accounts |
139 zum 31.12.2013 eingereicht am
11.09.2014 |
|
power
of representation |
1 Die Gesellschaft wird, wenn mehrere
Geschäftsführer |
|
other
provisions |
8 Der Aufsichtsrat besteht aus sechs
Mitgliedern. |
|
|
|
Proxy
|
|
|
CT Sibylla Härtel, geb. 21.10.1962 |
|
|
|
|
supervisory
board
|
|
|
CX Helmut Pancheri, geb. 05.07.1961 |
|
|
|
|
managing
director
|
|
|
BD Mag. Hubert Hirzinger, geb. 10.05.1957 |
|
|
|
|
Shareholder
|
|
|
CM Novartis Holding AG |
|
|
|
|
general
table
|
|
|
Landesgericht
Innsbruck |
|
|
Year
of incorporation |
1965 |
|
Date
of registration |
1965-11-26 |
|
from |
to |
company
name |
|
|
2003-05-02 |
Biochemie
GmbH |
|
2003-05-02 |
|
Sandoz
GmbH |
|
from |
to |
asset |
|
|
|
2001-10-05 |
ATS |
450.000.000,00 |
|
2001-10-05 |
|
EUR |
32.703.000,00 |
|
from |
to |
position |
name |
|
2009-02-19 |
2010-07-29 |
chairman
of the supervisory board |
Dr.
Horst Uwe Groh |
|
2010-07-29 |
2013-10-05 |
chairman
of the supervisory board |
Mag.
Christian Seiwald |
|
|
2014-07-16 |
chairman
of the supervisory board |
Hans
Helmut Michael Fabry |
|
1995-06-21 |
1997-05-16 |
deputy
chairman of the supervisory board |
Dr.
Daniel Vasella |
|
1999-10-12 |
2000-11-30 |
deputy
chairman of the supervisory board |
Dr.
Argeric Karabelas |
|
1997-05-16 |
2002-03-12 |
deputy
chairman of the supervisory board |
Dr.
Jörg Reinhardt |
|
2000-11-30 |
2002-05-30 |
deputy
chairman of the supervisory board |
Thomas
Ebeling |
|
2002-05-30 |
2005-04-19 |
deputy
chairman of the supervisory board |
Paul
Choffat |
|
2005-04-19 |
2010-07-29 |
deputy
chairman of the supervisory board |
Mag.
Christian Seiwald |
|
2010-07-29 |
2012-09-26 |
deputy
chairman of the supervisory board |
Christina
Ackermann Swistara |
|
|
2013-10-05 |
deputy
chairman of the supervisory board |
Peter
Goldschmidt |
|
|
2014-07-16 |
deputy
chairman of the supervisory board |
Dr.
Josef Egerbacher |
|
|
1997-05-16 |
member
of the supervisory board |
Dr.
Raymund Breu |
|
|
1998-04-18 |
member
of the supervisory board |
Daniel
Wagniere |
|
1998-04-18 |
1999-08-06 |
member
of the supervisory board |
Dr.
Hans Kindler |
|
1997-05-16 |
1999-08-06 |
member
of the supervisory board |
Dr.
Erwin Schillinger |
|
1999-08-06 |
1999-10-12 |
member
of the supervisory board |
Dipl-Ing.Dr.
Oswald Sellemond |
|
1999-08-06 |
2001-10-02 |
member
of the supervisory board |
Mag.
Christian Seiwald |
|
2001-10-02 |
2002-05-30 |
member
of the supervisory board |
Dipl-Ing.Dr.
Oswald Sellemond |
|
2002-03-12 |
2005-07-14 |
member
of the supervisory board |
Dr.
Urs Bärlocher |
|
2005-07-14 |
2007-03-16 |
member
of the supervisory board |
Kevin
Plummer |
|
2002-05-30 |
2007-06-28 |
member
of the supervisory board |
Dr.
Erwin Schillinger |
|
1999-08-06 |
2008-08-01 |
member
of the supervisory board |
Hermann
Egger |
|
2007-06-28 |
2008-08-01 |
member
of the supervisory board |
Dr.
Peter Jager |
|
2008-08-01 |
2009-03-11 |
member
of the supervisory board |
Knut
Mager |
|
2009-03-11 |
2010-04-20 |
member
of the supervisory board |
Dr.
Andreas Rummelt |
|
2010-04-20 |
2010-07-29 |
member
of the supervisory board |
Christina
Ackermann Swistara |
|
2010-07-29 |
2010-09-22 |
member
of the supervisory board |
Dr.
Horst Uwe Groh |
|
2007-03-16 |
2011-06-30 |
member
of the supervisory board |
Dipl-Ing.Dr.
Heinrich Scherfler |
|
2010-09-22 |
2012-03-09 |
member
of the supervisory board |
Dr.
Gerhard Schaefer |
|
|
2013-10-05 |
member
of the supervisory board |
Dr.
Josef Egerbacher |
|
2011-06-30 |
2013-10-05 |
member
of the supervisory board |
Hans
Helmut Michael Fabry |
|
|
2014-07-16 |
member
of the supervisory board |
Dr.
Andreas Brutsche |
|
|
1998-01-24 |
employee's
representative on the supervisory board |
Johann
Auer |
|
|
1999-08-06 |
employee's
representative on the supervisory board |
Helmuth
Stubenvoll |
|
1997-11-07 |
2002-10-01 |
joint
signing clerk |
Dr.
Helmut Deimel |
|
1999-04-15 |
2003-03-19 |
joint
signing clerk |
Mag.
Gerhard Hörl |
|
1993-09-23 |
2003-04-29 |
joint
signing clerk |
Mag.
Bernhard Sigl |
|
1999-08-17 |
2003-04-29 |
joint
signing clerk |
Mag.Dr.
Franz Stumpf |
|
2001-10-02 |
2003-12-18 |
joint
signing clerk |
MMag.Dr.
Johannes Gerstenbauer |
|
1998-01-27 |
2003-12-18 |
joint
signing clerk |
Mag.
Gottfried Rieser |
|
2003-05-06 |
2004-11-03 |
joint
signing clerk |
Mag.
Siegfried Johann Leitner |
|
1998-02-02 |
2005-03-08 |
joint
signing clerk |
Peter
Haselböck |
|
1993-09-23 |
2005-03-08 |
joint
signing clerk |
Dr.
Ernst Leitner |
|
1998-01-27 |
2006-05-16 |
joint
signing clerk |
Dr.
Santiago Alonso Ciriza |
|
2004-08-10 |
2006-05-16 |
joint
signing clerk |
Knut
Ulrich Mager |
|
2000-03-14 |
2006-05-16 |
joint
signing clerk |
Hans
Schaller |
|
1993-09-23 |
2007-02-09 |
joint
signing clerk |
Mag.
Rupert Labner |
|
2006-06-23 |
2007-06-15 |
joint
signing clerk |
Lorraine
Lynne Christina Perry |
|
2003-10-01 |
2007-06-15 |
joint
signing clerk |
Mag.Dr.
Otto Scheidl |
|
2002-07-17 |
2007-06-15 |
joint
signing clerk |
Dr.
Elisabeth Schneider Scherzer |
|
1998-04-02 |
2007-06-15 |
joint
signing clerk |
Dr.
Bruno Wallnöfer |
|
2000-01-12 |
2007-06-15 |
joint
signing clerk |
Mag.
Barbara Weigl Aman |
|
2004-10-06 |
2008-05-29 |
joint
signing clerk |
MBA.
Elgar Schnegg |
|
2000-05-31 |
2009-02-19 |
joint
signing clerk |
Kurt
Unterkircher |
|
2000-01-12 |
2010-01-09 |
joint
signing clerk |
Dr.
Josef Egerbacher |
|
1993-09-23 |
2010-03-19 |
joint
signing clerk |
Mag.
Friedrich Fuchs |
|
2008-05-29 |
2010-06-18 |
joint
signing clerk |
Dipl-Betriebsw.
Björn Komischke |
|
2006-06-23 |
2011-02-10 |
joint
signing clerk |
Mag.
Helmuth Hofer |
|
2001-12-19 |
2012-05-01 |
joint
signing clerk |
Dr.
Maria Schmalzl |
|
2010-06-18 |
2012-09-21 |
joint
signing clerk |
Dr.
Gerhard van der Meij |
|
1998-01-27 |
2012-10-17 |
joint
signing clerk |
Dr.
Elmar Dolejsi |
|
|
2014-03-18 |
joint
signing clerk |
Dr.
Friedrich Sernetz |
|
1993-05-10 |
1997-05-16 |
chairman
of the supervisory board |
Dr.
Urs Bärlocher |
|
1997-05-16 |
1998-04-18 |
chairman
of the supervisory board |
Pierre
Douaze |
|
1998-04-18 |
1999-10-12 |
chairman
of the supervisory board |
Dr.
Argeric Karabelas |
|
1999-10-12 |
2001-10-02 |
chairman
of the supervisory board |
Dipl-Ing.Dr.
Oswald Sellemond |
|
2001-10-02 |
2002-05-30 |
chairman
of the supervisory board |
Mag.
Christian Seiwald |
|
2002-05-30 |
2005-04-19 |
chairman
of the supervisory board |
Mag.
Christian Seiwald |
|
2005-04-19 |
2009-02-19 |
chairman
of the supervisory board |
Dr.
Andreas Rummelt |
|
|
1999-04-13 |
manager |
Dipl-Ing.Dr.
Oswald Sellemond |
|
|
2003-04-29 |
manager |
Werner
Meßner |
|
2003-04-29 |
2004-09-01 |
manager |
Mag.Dr.
Franz Stumpf |
|
2003-04-29 |
2005-07-28 |
manager |
Mag.
Hubert Hirzinger |
|
2003-04-29 |
2005-07-28 |
manager |
Dr.
Patrick Vink |
|
|
2006-06-03 |
manager |
Dipl-Ing.Dr.
Heinrich Scherfler |
|
2004-09-01 |
2007-06-06 |
manager |
Mag.
Johannes Schwertner |
|
2003-04-29 |
2008-02-21 |
manager |
Mag.
Bernhard Sigl |
|
2008-02-21 |
2010-02-20 |
manager |
Dipl-Ing.
Bianca Stöhr |
|
2010-01-09 |
2012-02-03 |
manager |
Mag.
Hannes Teißl |
|
2010-11-13 |
2012-12-18 |
manager |
Mag.
Richard Kronbichler |
|
2010-02-20 |
2014-01-22 |
manager |
Dr.
Peter Gasteiger |
|
2010-01-09 |
2014-05-15 |
manager |
Dr.
Günter Stempfer |
|
2006-06-03 |
2015-02-24 |
manager |
Dipl-Ing.
Ernst Meijinders |
|
1993-09-23 |
1999-02-16 |
joint
signing clerk |
Dr.
Paul Inama Sternegg |
|
1998-10-20 |
1999-04-15 |
joint
signing clerk |
Eric
Gorka |
|
1993-09-23 |
2000-09-13 |
joint
signing clerk |
Dr.
Otto Streichsbier |
|
1993-09-23 |
2000-10-11 |
joint
signing clerk |
Mag.
Hubert Hirzinger |
|
1993-09-23 |
2001-03-13 |
joint
signing clerk |
Dr.
Eberhard Pirich |
|
1993-09-23 |
2001-10-02 |
joint
signing clerk |
Dr.
Walter Killiches |
|
1998-01-27 |
2002-04-25 |
joint
signing clerk |
Mag.
Vinzenz Plörer |
|
from |
to |
position |
name |
|
|
1997-02-22 |
partner |
Sandoz
Holding AG |
|
1997-02-22 |
2000-08-26 |
partner |
Novartis
AG |
|
from |
to |
company
name |
|
1996-05-08 |
1998-11-24 |
Novartis
Handelsgesellschaft m.b.H. |
|
2004-09-16 |
2004-10-23 |
Novartis
Forschungsinstitut GmbH |
|
2005-01-27 |
2005-10-06 |
Grandis
Handel mit pharmazeutischen Produkten Gesellschaft mbH |
|
2006-01-24 |
2007-11-10 |
Nabriva
Therapeutics AG |
|
1993-12-17 |
2014-05-09 |
Biozym
GmbH in Liqu. |
|
1996-12-03 |
2014-10-08 |
Novartis
Animal Health GmbH |
|
On |
position |
name |
|
2014-10-08 |
merged
with |
Novartis
Animal Health GmbH |
|
2006-12-14 |
merged
with |
Sandoz
GmbH |
|
2005-10-06 |
merged
with |
Grandis
Handel mit pharmazeutischen Produkten Gesellschaft mbH |
|
2000-11-24 |
merged
with |
Novartis
Handelsgesellschaft m.b.H. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.64.01 |
|
|
1 |
Rs.99.84 |
|
Euro |
1 |
Rs.70.16 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
ASH |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.